DIK Stock Chart & Stats
€14.50
-€0.30(-2.21%)
At close: 4:00 PM EST
€14.50
-€0.30(-2.21%)
Day’s Range― - ―
52-Week Range€12.00 - €24.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.58B
Enterprise Value€601.72K
Total Cash (Recent Filing)€37.00B
Total Debt (Recent Filing)€237.88B
Price to Earnings (P/E)20.8
Beta0.48
Next Earnings
Nov 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)157.04
Shares Outstanding88,555,840
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)0.98
Price to Sales (P/S)0.79
P/FCF Ratio-9.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.19
Revenue Forecast (FY)€2.47B
Bulls Say, Bears Say
Bulls Say
Diversified Specialty Materials PortfolioExposure to multiple end markets reduces dependence on any single customer sector and supports resilience across industry cycles. Specialty and performance materials can also create customer qualification barriers and recurring B2B demand.
Manageable Balance-sheet LeverageModerate leverage and a steadily expanding asset base provide financial capacity to support operations and investment. Although leverage has risen, the balance sheet remains serviceable for a diversified chemicals manufacturer.
2026 Operating RecoveryThe 2026 recovery shows that earnings and operating cash generation can improve when market conditions and execution support the business. This provides a base for stabilization, although the durability of the rebound still needs confirmation.
Bears Say
Persistently Negative Free Cash FlowRepeated negative free cash flow limits internally funded growth and may reflect heavy investment, working-capital pressure, or weak cash conversion. Sustained outflows could constrain financial flexibility even as operating cash flow improves.
Cyclical And Uneven EarningsVolatile revenue, margins, and net income indicate inconsistent earnings power across the cycle. This makes profitability less predictable and increases reliance on end-market recovery, product mix, and pricing execution.
Rising Leverage And Weak ReturnsHigher leverage combined with modest or negative returns suggests the company is not consistently generating strong returns on its asset and equity base. This can reduce balance-sheet improvement and limit capacity to absorb prolonged weakness.
Denka Co News
DIK FAQ
What was Denka Co Ltd’s price range in the past 12 months?
Denka Co Ltd lowest stock price was €12.00 and its highest was €24.40 in the past 12 months.
What is Denka Co Ltd’s market cap?
Denka Co Ltd’s market cap is €1.58B.
When is Denka Co Ltd’s upcoming earnings report date?
Denka Co Ltd’s upcoming earnings report date is Nov 09, 2026 which is in 60 days.
How were Denka Co Ltd’s earnings last quarter?
Denka Co Ltd released its earnings results on Aug 07, 2026. The company reported €0.182 earnings per share for the quarter.
Is Denka Co Ltd overvalued?
According to Wall Street analysts Denka Co Ltd’s price is currently Overvalued.
Does Denka Co Ltd pay dividends?
Denka Co Ltd does not currently pay dividends.
What is Denka Co Ltd’s EPS estimate?
Denka Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Denka Co Ltd have?
Denka Co Ltd has 88,555,840 shares outstanding.
What happened to Denka Co Ltd’s price movement after its last earnings report?
Denka Co Ltd reported an EPS of €0.182 in its last earnings report. Following the earnings report the stock price went down -6.863%.
Which hedge fund is a major shareholder of Denka Co Ltd?
Currently, no hedge funds are holding shares in DE:DIK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Denka Co Ltd
Denka Company Limited, a Tokyo, Japan-based entity founded in 1915, operates internationally as a manufacturer and supplier of a wide array of organic and inorganic materials, electronic components, and pharmaceutical products. Its Electronics & Innovative Products division delivers specialized solutions like conductive agents essential for lithium-ion batteries, advanced thermal management materials, various substrates, high-performance ceramics, and adhesive films and tapes. The Life Innovation segment is dedicated to the production of influenza vaccines, the development of rapid diagnostic test kits for infectious diseases such as the novel coronavirus, and the provision of macromolecular sodium hyaluronate preparations. Within its Elastomers & Infrastructure Solutions division, the company offers functional elastomers, cement and specialized cement additives, agricultural fertilizers, and corrugated piping designed for farming applications. Lastly, the Polymer Solutions division focuses on polymer-based offerings, including styrene resins, sheets used for food packaging, synthetic fibers utilized in wigs and hairpieces, and other chemical compounds like poval. The company, initially incorporated as Denki Kagaku Kogyo Kabushiki Kaisha, officially adopted its current name, Denka Company Limited, in October 2015.
Technical Analysis
Mitsubishi Chemical Holdings
―
Shin-Etsu Chemical Co
―
Sumitomo Chemical Co
―
Tosoh
―
Nippon Shokubai Co., Ltd.
―








